Article

Dr. James Tsai oversees department at Yale

New Haven, CT-Glaucoma specialist James C. Tsai, MD, MBA, has been named chairman of the Yale School of Medicine's Department of Ophthalmology and Visual Science.

New Haven, CT-Glaucoma specialist James C. Tsai, MD, MBA, has been named chairman of the Yale School of Medicine's Department of Ophthalmology and Visual Science.

Dr. Tsai previously worked at the Edward S. Harkness Eye Institute of the Columbia University College of Physicians and Surgeons in New York. He is studying whether erythropoietin, a hormone made by the kidney that aids in red blood cell formation, can protect the optic nerve against glaucoma. Dr. Tsai succeeds M. Bruce Shields, MD, who had led the department since 1996.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) From MIGS to gene therapy: Inder Paul Singh, MD, celebrates the past and future of glaucoma care
(Image credit: Ophthalmology Times) NeuroOp Guru: Using OCT to forecast outcomes in ethambutol optic neuropathy
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
© 2025 MJH Life Sciences

All rights reserved.